Related Experiment Video

Updated: Apr 23, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

2.7K

Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells

Masashi Idogawa1, Tomoko Ohashi1, Jun Sugisaka2

  • 1Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. Contributed equally to this work.

Oncotarget
|October 4, 2014
PubMed

Insights

Researchers identified shRNA-58335, a novel RNAi sequence that enhances p53-induced apoptosis in cancer cells resistant to this cell death pathway. This discovery offers a promising strategy for improving p53-based cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • p53 transduction shows promise as a cancer therapy but faces limitations due to apoptosis resistance in some human cancers.
  • Identifying factors that overcome apoptosis resistance is crucial for enhancing p53-based cancer treatments.

Purpose of the Study:

  • To discover RNA interference (RNAi) sequences that enhance p53-induced apoptosis in cancer cells.
  • To identify novel therapeutic targets for overcoming resistance to p53-mediated apoptosis.

Main Methods:

  • Genome-wide screening of a lentiviral shRNA library in liver (Huh-7) and pancreatic (Panc-1) cancer cell lines resistant to p53-induced apoptosis.
  • Analysis of shRNA-treated cell populations using microarray after adenovirus-mediated p53 expression.
  • In vitro and in vivo validation of identified shRNAs, including shRNA-58335, and assessment of their effects on apoptosis and tumor growth.

Main Results:

  • shRNA-58335 was identified as a sequence significantly decreased in p53-transduced cancer cells, indicating its role in apoptosis.
  • shRNA-58335 demonstrated enhancement of p53-related apoptosis in vitro and augmented tumor growth inhibition in vivo.
  • The pro-apoptotic effect of shRNA-58335 was confirmed with PRIMA-1, a drug that reactivates mutant p53.

Conclusions:

  • shRNA-58335 effectively induces apoptosis in cancer cells resistant to p53, whether through p53 transduction or functional restoration.
  • Combining p53 restoration with RNAi-based therapies like shRNA-58335 represents a potentially powerful new approach for cancer treatment.

More Related Videos

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells09:12

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

Published on: December 21, 2011

21.6K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.1K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.0K